These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11090072)

  • 41. Oligoclonal T cell expansion in blood but not in the thymus from a patient with thymoma-associated pure red cell aplasia.
    Fujishima N; Hirokawa M; Fujishima M; Wada C; Toyoshima I; Watanabe S; Sawada K
    Haematologica; 2006 Dec; 91(12 Suppl):ECR47. PubMed ID: 17194653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.
    Mineo TC; Tamburrini A; Schillaci O; Ambrogi V
    Semin Thorac Cardiovasc Surg; 2018; 30(2):222-227. PubMed ID: 29522809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thymoma and paraneoplastic myasthenia gravis.
    Marx A; Willcox N; Leite MI; Chuang WY; Schalke B; Nix W; Ströbel P
    Autoimmunity; 2010 Aug; 43(5-6):413-27. PubMed ID: 20380583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Invasive thymoma with CD4+CD8+ double-positive T cell lymphocytosis.
    Tamaoki J; Chiyotani A; Nagai A; Konno K
    Respiration; 1997; 64(2):176-8. PubMed ID: 9097357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-color flow cytometric study on lymphocytes derived from thymic diseases.
    Okumura M; Fujii Y; Miyoshi S; Shiono H; Inoue M; Kadota Y; Fukuhara K; Matsuda H
    J Surg Res; 2001 Dec; 101(2):130-7. PubMed ID: 11735267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymectomy and systemic lupus erythematosus (SLE).
    Panarese A; D'Andrea V; Pironi D; Filippini A
    Ann Ital Chir; 2014; 85(6):617-8. PubMed ID: 25919914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
    van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO
    Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perivascular infiltrate of memory lymphocytes and mature dendritic cells in MG thymomas.
    Nagane Y; Utsugisawa K; Akutsu H; Sato Y; Terayama Y
    Neurology; 2005 Sep; 65(5):770-2. PubMed ID: 16157920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurofilament is an autoantigenic determinant in myasthenia gravis.
    Schultz A; Hoffacker V; Wilisch A; Nix W; Gold R; Schalke B; Tzartos S; Müller-Hermelink HK; Marx A
    Ann Neurol; 1999 Aug; 46(2):167-75. PubMed ID: 10443881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
    Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
    J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
    Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract]   [Full Text] [Related]  

  • 52. Alterations of the immune system in thymic malignancies.
    Weksler B; Lu B
    J Thorac Oncol; 2014 Sep; 9(9 Suppl 2):S137-42. PubMed ID: 25396311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
    Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
    J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Non-motor symptoms in myasthenia gravis: attributed to T-cell clones from thymoma].
    Suzuki S
    Brain Nerve; 2013 Apr; 65(4):477-83. PubMed ID: 23568996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Thymectomy in myasthenia gravis. Evaluation of the results in 73 patients].
    de Assis JL; Curi N
    Arq Neuropsiquiatr; 1978 Mar; 36(1):16-26. PubMed ID: 637742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered naive CD4
    Kohler S; Keil T; Alexander T; Thiel A; Swierzy M; Ismail M; Rückert JC; Meisel A
    J Neuroimmunol; 2019 Feb; 327():10-14. PubMed ID: 30686546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
    [No Abstract]   [Full Text] [Related]  

  • 58. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.
    Shirai T; Miyata M; Nakase A; Itoh T
    Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells.
    Gilhus NE; Willcox N; Harcourt G; Nagvekar N; Beeson D; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1995 Jan; 56(1):65-76. PubMed ID: 7822483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
    Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink HK; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
    J Pathol; 2007 Apr; 211(5):563-571. PubMed ID: 17334980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.